These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 38103812)
1. Long-term systolic blood pressure variability independent of mean blood pressure is associated with mortality and cardiovascular events: A systematic review and meta-analysis. Saputra PBT; Lamara AD; Saputra ME; Pasahari D; Kurniawan RB; Farabi MJA; Multazam CECZ; Oktaviono YH; Alkaff FF Curr Probl Cardiol; 2024 Feb; 49(2):102343. PubMed ID: 38103812 [TBL] [Abstract][Full Text] [Related]
2. Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study. Wu C; Shlipak MG; Stawski RS; Peralta CA; Psaty BM; Harris TB; Satterfield S; Shiroma EJ; Newman AB; Odden MC; Am J Hypertens; 2017 Feb; 30(2):151-158. PubMed ID: 27600581 [TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of long-term SBP variability in high-risk hypertension. Del Pinto R; Pietropaoli D; Dobre M; Ferri C J Hypertens; 2020 Nov; 38(11):2237-2244. PubMed ID: 32649637 [TBL] [Abstract][Full Text] [Related]
4. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Suchy-Dicey AM; Wallace ER; Mitchell SV; Aguilar M; Gottesman RF; Rice K; Kronmal R; Psaty BM; Longstreth WT Am J Hypertens; 2013 Oct; 26(10):1210-7. PubMed ID: 23744496 [TBL] [Abstract][Full Text] [Related]
5. Effect of exercise training on blood pressure variability in adults: A systematic review and meta-analysis. Lin M; Lin Y; Li Y; Lin X PLoS One; 2023; 18(10):e0292020. PubMed ID: 37851627 [TBL] [Abstract][Full Text] [Related]
6. Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis. Diallo A; Carlos-Bolumbu M; Galtier F Acta Diabetol; 2023 Dec; 60(12):1651-1662. PubMed ID: 37439858 [TBL] [Abstract][Full Text] [Related]
7. Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial. Bangalore S; Fayyad R; Messerli FH; Laskey R; DeMicco DA; Kastelein JJ; Waters DD Am J Cardiol; 2017 Feb; 119(3):379-387. PubMed ID: 27939230 [TBL] [Abstract][Full Text] [Related]
8. Visit-to-visit Systolic Blood Pressure Variability and Stroke Risk: A Systematic Review and Meta-analysis. Wang H; Li M; Xie SH; Oyang YT; Yin M; Bao B; Chen ZY; Yin XP Curr Med Sci; 2019 Oct; 39(5):741-747. PubMed ID: 31612391 [TBL] [Abstract][Full Text] [Related]
9. Association of low diastolic blood pressure with cardiovascular outcomes and all-cause mortality: A meta-analysis. Siddiqi TJ; Usman MS; Siddiqui A; Salman A; Talbot N; Khan LA; Shabbir A; Hall ME; Taffet GE Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102131. PubMed ID: 37866417 [TBL] [Abstract][Full Text] [Related]
10. The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients. Sarafidis PA; Loutradis C; Karpetas A; Tzanis G; Bikos A; Raptis V; Syrgkanis C; Liakopoulos V; Papagianni A; Bakris G; Parati G Nephrol Dial Transplant; 2019 Mar; 34(3):515-523. PubMed ID: 30184172 [TBL] [Abstract][Full Text] [Related]
11. Blood Pressure Control Targets and Risk of Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage. Teo KC; Keins S; Abramson JR; Leung WCY; Leung IYH; Wong YK; Yeung C; Kourkoulis C; Warren AD; Chan KH; Cheung RTF; Ho SL; Gurol ME; Viswanathan A; Greenberg SM; Anderson CD; Lau KK; Rosand J; Biffi A Stroke; 2023 Jan; 54(1):78-86. PubMed ID: 36321455 [TBL] [Abstract][Full Text] [Related]
12. Impact of Visit-to-Visit Variability in Systolic Blood Pressure on Cardiovascular Outcomes in Korean National Health Insurance Service-National Sample Cohort. Choi S; Shin J; Choi SY; Sung KC; Ihm SH; Kim KI; Kim YM Am J Hypertens; 2017 Jun; 30(6):577-586. PubMed ID: 28052880 [TBL] [Abstract][Full Text] [Related]
13. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2. Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700 [TBL] [Abstract][Full Text] [Related]
14. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease. Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850 [TBL] [Abstract][Full Text] [Related]
15. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication. Jeffers BW; Robbins J; Bhambri R; Wajsbrot D Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570 [TBL] [Abstract][Full Text] [Related]
16. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative. Ferreira JP; Duarte K; Pfeffer MA; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P; Eur J Heart Fail; 2018 Feb; 20(2):323-331. PubMed ID: 29314455 [TBL] [Abstract][Full Text] [Related]
17. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138 [TBL] [Abstract][Full Text] [Related]
18. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737 [TBL] [Abstract][Full Text] [Related]
19. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709 [TBL] [Abstract][Full Text] [Related]